Skip to content
Wholesale trade
KZActiveBIN 980341002699
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 17
To risks

АКМОЛИНСКИЙ ФИЛИАЛ ТОО "КАЗАХСКАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПАНИЯ "МЕДСЕРВИС ПЛЮС"

Director
Касымова Гульнара Сапаровна
Incorporated
18.03.1998
Address
Астана ул. БЕЙІМБЕТ МАЙЛИН, 15

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/17

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
АКМОЛИНСКИЙ ФИЛИАЛ ТОВАРИЩЕСТВА С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "КАЗАХСКАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПАНИЯ "МЕДСЕРВИС ПЛЮС"
BIN
980341002699
Status
Active
Director
Касымова Гульнара Сапаровна
Registration date
18.03.1998
Activity
Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями
Legal address
Астана ул. БЕЙІМБЕТ МАЙЛИН, 15
VAT payer
No
КАТО
711110000
КФС
Собственность совместных предприятий с иностранным участием
КСЕ
Нефинансовые корпорации под иностранным контролем – ОПП
Company size
Малые предприятия
Employees
от 51 до 100 чел.

Activities

2
46461primary

Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями

Secondary

  • 47731Розничная торговля фармацевтическими товарами в специализированных магазинах, являющихся торговыми объектами, с торговой площадью менее 2000 кв.м
Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
34.2M
2025
50.6M+17%
2024
43.2M+17%
2023
36.8M+22%
2022
30.1M+283%
2021
7.9M
·34.2M
2026year to date
+17%50.6M
2025
+17%43.2M
2024
+22%36.8M
2023
+283%30.1M
2022
·7.9M
2021
2026
Tax paid34,224,032 ₸
Penalty0 ₸
Fine191,681 ₸
VAT refund0 ₸
2025
Tax paid50,591,094 ₸
Penalty3,000 ₸
Fine119,926 ₸
VAT refund0 ₸
2024
Tax paid43,151,840 ₸
Penalty0 ₸
Fine131,066 ₸
VAT refund0 ₸
2023
Tax paid36,761,356 ₸
Penalty0 ₸
Fine143,402 ₸
VAT refund0 ₸
2022
Tax paid30,086,547 ₸
Penalty0 ₸
Fine44,414 ₸
VAT refund0 ₸
2021
Tax paid7,863,980 ₸
Penalty0 ₸
Fine225,651 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • КГ

    Касымова Гульнара Сапаровна

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

АКМОЛИНСКИЙ ФИЛИАЛ ТОО "КАЗАХСКАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПАНИЯ "МЕДСЕРВИС ПЛЮС" (BIN 980341002699) is an active legal entity in Астана, registered in 1998 (28 years on the market). Primary activity — оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями. Per open government registries as of November 8, 2026: 288 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 554,123,152 ₸. Automated screening of open registries found no risk indicators for "КАЗАХСКАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПАНИЯ ". Director on record — Касымова Гульнара Сапаровна. Data current as of November 8, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.